'Compassionate use' and other means of accessing unproven, unapproved treatments could impact long-term medical benefits

Wednesday, September 17, 2014 - 00:31 in Health & Medicine

Patients facing death or irreversible disease progression -– most of whom have exhausted all approved treatment options -- sometimes seek access to unapproved and unproven interventions. This type of access, often referred to as “compassionate use,” is unregulated by federal authorities, subject to corporate pharmaceutical policies that change mid-stream, and could potentially adversely affect clinical care in the future, according to preliminary studies.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net